The serine/threonine kinase Akt/PKB plays a critical role in executing multiple cellular metabolic pathways and in particular cellular energy metabolism. It can mediate cell survival, cell proliferation, cell growth and differentiation. Up-regulation of Akt activity can lead to tumorigenesis, whereas down-regulation of Akt activity can lead to degenerative diseases. We have previously shown that Akt is a major downstream effector of growth factor mediated cell survival. To determine the role of Akt in vivo and to genetically dissect its activities we have generated Akt knock-out (KO) mice and thus provided genetic evidence that Akt is required for cell survival in mammalian cells. Systematic analysis reveals that Akt intervenes in the apoptotic cascade by maintaining the integrity of mitochondria and inhibition of cytochrome c release. The ability of Akt to maintain mitochondrial integrity is dependent on glucose availability. Experimental evidence suggests that Akt mediates cell survival, at least in part, through the increase of mitochondrial hexokinase (mtHK) activity associated with mitochondria. The fact that mtHKs catalyze the first committed step in glycolysis, and their mitochondrial localization couples glucose metabolism to mitochondrial ATP synthesis, may explain the dependency of Akt-mediated cell survival on glucose. We propose that Akt-mediated cellular energy metabolism is recruited to the apoptotic cascade in mammalian cells. During the previous funding period we have shown the role of Akt in the regulation of the target of rapamycin (mTOR) and protein synthesis that are determinants of cell mass and cellular atrophy. We intend to verify whether the function of Akt in energy metabolism also contributes to the activity of mTOR and to cell mass. Our long-term goal is to dissect the functions of Akt in cell survival, cell growth, cellular metabolism, and differentiation and to understand how these functions interact with each other. To achieve this goal we have generated individual KO and DKO of the 3 akt genes and have been analyzing the phenotypes of these mice. In this grant application we will verify a link between the role of Akt in energy metabolism and its abilities to mediate cell survival and cell growth (cell mass). We will use the Akt KO mice and cells derived from these mice to provide genetic evidence for the role of Akt in these processes. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG016927-07
Application #
6775545
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Sierra, Felipe
Project Start
1998-09-01
Project End
2008-07-31
Budget Start
2004-09-15
Budget End
2005-07-31
Support Year
7
Fiscal Year
2004
Total Cost
$385,820
Indirect Cost
Name
University of Illinois at Chicago
Department
Biochemistry
Type
Schools of Medicine
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
DeWaal, Dannielle; Nogueira, Veronique; Terry, Alexander R et al. (2018) Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nat Commun 9:446
Nogueira, Veronique; Patra, Krushna C; Hay, Nissim (2018) Selective eradication of cancer displaying hyperactive Akt by exploiting the metabolic consequences of Akt activation. Elife 7:
Liu, Shu-Lin; Wang, Zhi-Gang; Hu, Yusi et al. (2018) Quantitative Lipid Imaging Reveals a New Signaling Function of Phosphatidylinositol-3,4-Bisphophate: Isoform- and Site-Specific Activation of Akt. Mol Cell 71:1092-1104.e5
Yu, Pengchun; Wilhelm, Kerstin; Dubrac, Alexandre et al. (2017) FGF-dependent metabolic control of vascular development. Nature 545:224-228
Kerr, Bethany A; West, Xiaoxia Z; Kim, Young-Woong et al. (2016) Stability and function of adult vasculature is sustained by Akt/Jagged1 signalling axis in endothelium. Nat Commun 7:10960
Hay, Nissim (2016) Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer 16:635-49
Wang, Qi; Yu, Wan-Ni; Chen, Xinyu et al. (2016) Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. Cancer Cell 29:523-535
Gao, Fei; Artham, Sandeep; Sabbineni, Harika et al. (2016) Akt1 promotes stimuli-induced endothelial-barrier protection through FoxO-mediated tight-junction protein turnover. Cell Mol Life Sci 73:3917-33
Yu, Wan-Ni; Nogueira, Veronique; Sobhakumari, Arya et al. (2015) Systemic Akt1 Deletion after Tumor Onset in p53(-/-) Mice Increases Lifespan and Regresses Thymic Lymphoma Emulating p53 Restoration. Cell Rep 12:610-21
Jeon, Sang-Min; Hay, Nissim (2015) The double-edged sword of AMPK signaling in cancer and its therapeutic implications. Arch Pharm Res 38:346-57

Showing the most recent 10 out of 50 publications